newsfilter
← Latest News
ACCESS Newswire·

Biophytis Regains Compliance with NASDAQ Minimum Bid Price Requirement

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 19, 2023 / Biophytis SA , a clinical-stage biotechnology company focused on the